Antibodies, Monoclonal
Showing 7326 - 7350 of 7,894
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (biological, drug, procedure)
Completed
- Leukemia
- +4 more
- alemtuzumab
- +5 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 3, 2012
Lung Cancer Trial in Canada, United States (biological, drug, radiation)
Terminated
- Lung Cancer
- monoclonal antibody 11D10 anti-idiotype vaccine
- +4 more
-
Mobile, Alabama
- +99 more
Jun 11, 2012
HLA Sensitization Following Major Cortical Allograft Bone
Completed
- Bone Cancer
- retrieve blood samples
-
Gainesville, FloridaUF Orthopaedics and Sports Medicine Institute
Oct 26, 2012
Lymphoma Trial in Atlanta (Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF)
Terminated
- Lymphoma
- Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
May 25, 2012
Pancreatic Cancer Trial in San Francisco (biological, drug, procedure)
Terminated
- Pancreatic Cancer
- bevacizumab
- +2 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Sep 13, 2012
Influenza Trial in Oxford (TIV and MVA-NP+M1, Saline and seasonal influenza vaccine TIV)
Completed
- Influenza
- TIV and MVA-NP+M1
- Saline placebo and seasonal influenza vaccine TIV
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Nov 28, 2012
HIV Trial in United States (KD-247, Physiological saline)
Completed
- HIV Infections
- KD-247
- Physiological saline
-
Beverly Hills, California
- +14 more
Nov 16, 2012
Psoriasis, Immunomodulation Trial in Little Rock (tofacitinib)
Completed
- Psoriasis
- Immunomodulation
-
Little Rock, ArkansasPfizer Investigational Site
Jan 16, 2013
Breast Cancer Trial (external beam radiation therapy, Herceptin)
Completed
- Breast Cancer
- external beam radiation therapy
- Herceptin
- (no location specified)
Aug 14, 2012
Colorectal Cancer Trial in Cleveland (bevacizumab, erlotinib HCl, fluorouracil)
Completed
- Colorectal Cancer
- bevacizumab
- +4 more
-
Cleveland, Ohio
- +2 more
Aug 31, 2012
Leukemia Trial in Belgium, Italy, Netherlands (gemtuzumab ozogamicin)
Unknown status
- Leukemia
- gemtuzumab ozogamicin
-
Antwerp, Belgium
- +44 more
Jul 23, 2012
Influenza, Human Trial in Baltimore (TCN-032, Placebo)
Completed
- Influenza, Human
- TCN-032
- Placebo
-
Baltimore, MarylandSNBL Clinical Pharmacology Center
Mar 30, 2012
Lung Cancer Trial in Worldwide (BCG vaccine, mAb BEC2)
Completed
- Lung Cancer
- BCG vaccine
- monoclonal antibody BEC2
-
Birmingham, Alabama
- +76 more
Mar 5, 2012
NSCLC Trial in United States (M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab)
Completed
- Non-small Cell Lung Cancer
- M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab
-
Bethesda, Maryland
- +3 more
Apr 25, 2012
Stage III-IV or Recurrent Endometrial Cancer Trial in Rome, (Bevacizumab, Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8
Unknown status
- Stage III-IV or Recurrent Endometrial Cancer
- Bevacizumab
- Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
-
Rome,, Rome, ItalyCatholic University of Sacred Heart Rome,
Jan 15, 2013